The Daily The Future of America’s Abortion Fight
Dec 16, 2021
Pam Belluck, a health and science writer for The New York Times, shares her insights on the evolving landscape of abortion rights in America. She discusses the optimistic push from anti-abortion activists to overturn Roe v. Wade, while abortion rights advocates anticipate potential changes in FDA regulations regarding mifepristone. The conversation highlights the rise of medication abortion, the role of telemedicine during the pandemic, and the complexities of accessing these services in various states, shedding light on ongoing public debates.
AI Snips
Chapters
Transcript
Episode notes
Modern Abortion Methods
- Abortion methods have changed since the 1970s, with medication abortions now making up over 40% of all abortions.
- This is due to the FDA approval of medication abortion in 2000, offering a nonsurgical option.
Medication Abortion and Regulations
- Medication abortion involves two pills taken up to 10 weeks into pregnancy, applicable to 80% of US abortions.
- The first pill, mifepristone, is strictly regulated, requiring in-person pickup from certified doctors.
Impact of Lifting Mifepristone Restrictions
- Removing the in-person requirement for mifepristone would lower barriers to abortion access.
- Telemedicine appointments and mail delivery offer increased privacy and convenience.